- Hustle Hub Stocks
- Posts
- Quest Diagnostics Incorporated DCF Stock Analysis. Buy or Sell?
Quest Diagnostics Incorporated DCF Stock Analysis. Buy or Sell?
Quest Diagnostics Incorporated DCF Stock Analysis.
Meet the Genius Who Invented Plastic That Dissolves in Water
The world produces 450 million tons of plastic waste each year. Microplastics are seeping into our oceans and food. They even show up in our bodies. So you can imagine how revolutionary a new kind of plastic that completely dissolves in water can be.
Thatʼs exactly what Timeplast created. They patented a water-soluble, time-programmable plastic that vanishes without harming the environment. Major players are already partnering with Timeplast—including a Fortune 500 company. Not only are they disrupting industries like packaging and 3D printing, their technology can also replace glass, metal, and paper.
For just a few more days, you can invest in Timeplast as they scale in their $1.3 trillion market. Become a Timeplast shareholder by midnight, 7/31.
This is a paid advertisement for Timeplast’s Regulation CF Offering. Please read the offering circular at invest.timeplast.com.
Quest Diagnostics Incorporated’s DCF Stock Analysis
Here’s my assumptions for $DGX ( ▲ 0.73% ) :
Risk Free Rate (10 Years Interest Rate Swap): 4.13%
Risk Premium (Taken from the Aswath Damodaran equity premium spreadsheet): 4.33%
Interest Rate Spread on The Risk free rate ( For the cost of debt calculation): 3%
Last 24 Months Beta: 0.25
Historical Data
Revenue growth in the last 10 years (CAGR): 2.80%
Earnings growth in the last 10 years (CAGR): 2.08%
Unlevered Free Cash Flow growth in the last 10 years (CAGR): 2.17%
Future Assumptions
End of Year FCF growth: 2%
Growth until end of 2026: 3%
Growth until end of 2034: 3%
Perpetual growth: 2.5%
Net Debt: 6.388B
Outstanding Stock Options Present Value Assumption: $0.205B
Restricted Stock Units + Performance Stock Units Present Value Assumption: $0.216B
Stock Valuation based on these assumptions: $195
Last update 07/21/2025
Data Source for the analysis: SEEKING ALPHA
CLAIM 20% OFF WITH MY LINK
All the content in this newsletter should be taken as informational content only. THIS IS NOT FINANCIAL ADVICE! Do your own Due Diligence before investing or contact a professional financial advisor.
I don’t have a position in Quest Diagnostics Incorporated (DGX) and I don’t plan to add a position in the coming days.